Literature DB >> 10440681

Evaluation of the New American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification.

T Ichikura1, S Tomimatsu, K Uefuji, M Kimura, T Uchida, D Morita, H Mochizuki.   

Abstract

BACKGROUND: A new system for the classification of gastric carcinoma, based on the number of metastatic lymph nodes, has been adopted by the current American Joint Committee on Cancer/International Union Against Cancer (AJCC/UICC) TNM system (1997). The purpose of this study was to evaluate the rationality of this classification in comparison with the Japanese classification, which is based on the location of positive lymph nodes.
METHODS: The authors analyzed 587 patients who underwent clinically curative gastrectomy with D2 lymphadenectomy for gastric carcinoma and each had 15 or more lymph nodes histologically examined from 1982 to 1992. Multivariate analysis with the Cox proportional hazards model was carried out to determine which classification was more effective.
RESULTS: Within the pN1 or pN2 category of the new AJCC/UICC system, no significant difference in the survival rates existed between n1 patients and n2 patients of the Japanese classification. On the other hand, the survival rates significantly decreased, in the order of pN1, pN2, and pN3 (from greatest to smallest decrease), within the n1 and n2 categories. In multivariate analysis, lymph node involvement by the AJCC/UICC classification was selected as the most significant prognostic determinant, whereas the Japanese lymph node classification was not significantly prognostic. When survival rates were calculated within the pT1, pT2, and pT3-4 categories, no differences existed between pN0 and pN1. There was some discrepancy between the survival rate for each pT and pN category and the corresponding stage.
CONCLUSIONS: The new AJCC/UICC classification for lymph node involvement of gastric carcinoma is basically acceptable and considered superior to the Japanese classification. Further analysis involving a greater number of cases may be necessary to confirm the applicability of this staging system. Copyright 1999 American Cancer Society.

Entities:  

Mesh:

Year:  1999        PMID: 10440681     DOI: 10.1002/(sici)1097-0142(19990815)86:4<553::aid-cncr2>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

1.  Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients.

Authors:  M S Karpeh; L Leon; D Klimstra; M F Brennan
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

2.  Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.

Authors:  Chang-Li Wang; Yue Li; Dong-Sheng Yue; Lian-Min Zhang; Zhen-Fa Zhang; Bing-Sheng Sun
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

3.  Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy.

Authors:  Chang-Ming Huang; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Bi-Juan Lin; Jia-Bin Wang
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

4.  Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.

Authors:  O Cheong; S T Oh; B S Kim; J H Yook; J H Kim; J T Im; G C Park
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

5.  Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus.

Authors:  Chang-Ming Huang; Bi-Juan Lin; Hui-Shan Lu; Xiang-Fu Zhang; Ping Li; Jian-Wei Xie
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

6.  A new pN staging system based on both the number and anatomic location of metastatic lymph nodes in gastric cancer.

Authors:  Jianhui Chen; Chuangqi Chen; Yulong He; KaiMing Wu; Hui Wu; Shirong Cai
Journal:  J Gastrointest Surg       Date:  2014-10-09       Impact factor: 3.452

7.  Differential Expression of SPARC in Intestinal-type Gastric Cancer Correlates with Tumor Progression and Nodal Spread.

Authors:  Konrad Franke; Stacy Carl-McGrath; Friedrich-Wilhelm Röhl; Uwe Lendeckel; Matthias Pa Ebert; Marc Tänzer; Matthias Pross; Christoph Röcken
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

8.  Prognostic significance of the metastatic lymph node ratio in gastric cancer patients.

Authors:  Naoto Fukuda; Yasuyuki Sugiyama; Akira Midorikawa; Hiroyuki Mushiake
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

9.  Close association of metastasis-associated protein 1 overexpression with increased angiogenesis and poor survival in patients with histologically node-negative gastric cancer.

Authors:  Xiaomei Deng; Lutao Du; Chuanxin Wang; Yongmei Yang; Juan Li; Hui Liu; Jian Zhang; Lili Wang; Xin Zhang; Wei Li; Xuhua Zhang; Shun Wang; Zhaogang Dong
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

10.  Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: adjuvant 5-FU/cisplatin and chemoradiation with capecitabine.

Authors:  Hyung-Sik Lee; Youngmin Choi; Won-Joo Hur; Hyo-Jin Kim; Hyuk-Chan Kwon; Sung-Hyun Kim; Jae-Seok Kim; Jong-Hoon Lee; Ghap-Joong Jung; Min-Chan Kim
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.